Browsing Tag
OTC pharma
1 post
Is Immuron (ASX: IMC) quietly staging a turnaround? PROIBS launch sparks 20% rally
Immuron (ASX: IMC) shares jumped 20 percent following its IBS product launch. Can the PROIBS rollout turn this microcap into a digestive health contender?